Table 2.
Differential expression of miRNAs in different tissues
| miRNAs | Tissues | Expression Levels |
|---|---|---|
| miR-30a-3p | T-NG | 3.58 (1.75–4.27) |
| T-PTC | 4.66 (3.54–5.37) * | |
| A-NG | 3.35 (2.27–3.66) ## | |
| A-PTC | 2.05 (0.61–2.96) **,##,Δ | |
| miR-122-5p | T-NG | 10.43 (9.98–12.79) |
| T-PTC | 10.52 (9.20–11.96) | |
| A-NG | 7.36 (6.66–7.98) **,## | |
| A-PTC | 7.55 (6.25–8.52) **,## | |
| miR-136-5p | T-NG | 10.60 (9.09–12.02) |
| T-PTC | 10.69 (9.09–11.34) | |
| A-NG | 7.56 (6.74–8.68) **,## | |
| A-PTC | 7.76 (6.94–8.82) **,## | |
| miR-146b-5p | T-NG | 3.12 (2.23–4.99) |
| T-PTC | −0.34 (−1.58–0.31) ** | |
| A-NG | 2.89 (1.92–4.30) ## | |
| A-PTC | 2.78 (1.52–3.84) ## | |
| miR-199b-5p | T-NG | 7.32 (5.79–7.90) |
| T-PTC | 4.6s7 (3.90–5.87) ** | |
| A-NG | 1.49 (0.68–4.22) **,## | |
| A-PTC | 3.31 (2.21–3.93) **,## |
The expression values were calculated by ΔCt. * p < 0.05, ** p < 0.01 vs. T-NG; # p < 0.05, ## p < 0.01 vs. T-PTC; Δp < 0.05 vs. A-NG. T-NG: benign thyroid nodular goiter tissue (n = 15); T-PTC: papillary thyroid carcinoma tissues (n = 36); A-NG: non-nodular tissue adjacent to benign thyroid nodular goiter (n = 15); A-PTC: non-tumor tissue adjacent to PTC (n = 36); miRNA expression levels are presented as the median and interquartile.